Abstract

Aveanna Healthcare Holdings Inc. will release its quarterly results on August 13, 2026 Pre-MKt; this preview summarizes consensus revenue, margin, net profit, and EPS expectations, as well as segment momentum and street positioning into the print.

Market Forecast

Street models indicate Aveanna Healthcare Holdings Inc. revenue for the current quarter is projected at 638.62 million US dollars, implying 19.29% year-over-year growth; the forecast embeds EBIT of 78.10 million US dollars with 70.24% year-over-year growth and EPS of 0.166, up 382.29% year over year. Forecast detail implies the company aims to expand profitability, with last quarter’s gross margin base at 31.71% and a net profit margin base of 6.43%, and EPS tracking toward material year-over-year expansion. Main business momentum points to stable volume in private duty services, offset by steady trends in home health and hospice and continued execution in medical solutions. The most promising segment is private duty services, with last quarter revenue of 535.65 million US dollars and durable demand drivers supporting year-over-year growth from increased authorized hours and clinician retention.

Last Quarter Review

Aveanna Healthcare Holdings Inc. delivered last quarter revenue of 647.92 million US dollars, a gross profit margin of 31.71%, GAAP net profit attributable to the parent company of 41.65 million US dollars, a net profit margin of 6.43%, and adjusted EPS of 0.18, which increased 80.00% year over year. A notable highlight was the positive operating leverage reflected in EBIT of 80.06 million US dollars, which outpaced expectations. Main business mix remained concentrated in private duty services at 535.65 million US dollars, with home health and hospice at 66.61 million US dollars and medical solutions at 45.65 million US dollars, underscoring a care-at-home model anchored in skilled nursing hours and pediatric acuity.

Current Quarter Outlook

Main business trajectory

Private duty services is the core revenue engine and the primary determinant of quarterly variability. Near-term growth should benefit from sustained payor authorization trends and staffing improvements, which raise delivered hours and reduce unstaffed cases. Margin sensitivity ties to wage inflation and shift mix; better scheduling density and clinician retention can lift gross margin from the prior 31.71% base, while any overtime normalization would support incremental operating leverage. Payer rate dynamics are pivotal: incremental rate wins or acuity mix improvement would pass through at high contribution margin, whereas unexpected rate pressure would dilute the net profit margin base of 6.43%.

Most promising segment

Private duty services remains the most scalable opportunity due to recurring hours and favorable demographics, as reflected in its last quarter revenue of 535.65 million US dollars. The model benefits from state Medicaid program stability and continued demand in high-acuity pediatric nursing, which historically tracks with authorized hours rather than discretionary utilization. Execution focus this quarter centers on clinician supply, time-to-hire, and retention; a modest uplift in filled-shift percentage can translate to measurable revenue gains and a stronger EBIT flow-through toward the 78.10 million US dollars forecast. Any incremental progress in case coverage and shift continuity would reinforce the Street’s EPS expectation of 0.166.

Factors influencing the stock this quarter

- Profitability cadence relative to the last quarter’s 31.71% gross margin and 6.43% net margin will shape sentiment; upside depends on labor efficiency and wage-rate spread versus reimbursement. - Mix and rate visibility in home health and hospice may contribute slightly to consolidation of margin if episodic volumes hold, but the segment is smaller and will largely act as a stabilizer. - Guidance quality is a critical catalyst: confirmation that revenue can track around 638.62 million US dollars with year-over-year growth of 19.29% while progressing toward the EBIT estimate of 78.10 million US dollars would support the majority bullish stance. Conversely, any commentary indicating hiring bottlenecks or rate headwinds could challenge the EPS trajectory from the 0.18 base in the prior quarter to 0.166 expected now.

Analyst Opinions

Bullish views dominate recent commentary and previews, with the majority highlighting improved operating leverage and favorable year-over-year comparisons underpinning the projected 19.29% revenue growth and 70.24% EBIT expansion. Analysts point to continued momentum in private duty services and an improving clinician supply backdrop that supports delivery of authorized hours, which is expected to translate into a healthier earnings mix and sustain the EPS ramp. The focus is on execution consistency: if Aveanna Healthcare Holdings Inc. demonstrates staffing stability and manageable wage dynamics, the forecast net profit trajectory should remain intact, reinforcing the constructive stance into August 13, 2026.